It doesn't make sense to extend drug patent lengths though because often enough, after the release of a compound, it takes just a few years for a new and updated version of it to be researched.
However, the counterpoint can also be made that it should be extended, as the permit process for medical compounds takes years and costs billions, with the short patent lifetime forcing pharma companies to command absurd prices just to recoup the R&D cost.
(IMHO: the system on how we research pharmaceuticals and how we fund it must be drastically reformed. The question is, how do we prevent China and India from just taking our research and copying it for free, it's already bad enough)
See insulin prices difference in europe vs US
centralize all chemistry research behind the closed doors, weapon-level export controls on U.S.-made fever drugs simply because they are U.S.-made, severely control international collaboration, and so much more.
the problem is that the scientific community will rightfully revolt and the rest of the world will pull ahead of the U.S. in a relatively short amount of time. plus, since open science will have been long dead in the U.S. under such conditions, random breakthroughs at a basement or a non-prestigious university will cease to exist as a concept.
China and India piggybacking is the least bad thing to happen. rather, it's an indicator of how open the open science in the U.S. is
So... the US and European tax- and insurance payers are supposed to pay the billions of dollars for R&D and amortization, just for China to copy everything?
It's bad enough if China does that for their internal market. But they don't stop there, their clones and fakes flood back into our markets as well, leading to regular warnings such as [1] from government authorities for consumer safety.
This is unsustainable on so many levels, it needs to stop.
[1] https://www.swissmedic.ch/swissmedic/de/home/humanarzneimitt...
I think this is an inversion of cause and effect.
They drop insane money up front to do a trial, get approved, and then have low single-digit years to recoup all that investment before the new medication goes off patent a competitor markets a generic that blows up the market and likely isn't as well-tested.
And then, in the extreme case, you might get blown away on the street and have your murderer canonized.
But I guess that AI will fix all these perverse incentives Real Soon Now.
Ahem
That was health insurance. Different beast.
Not excusing pharma, but that bit of extreme casting doesn’t really belong in the conversation.
Like most things in life, “It Depends” is probably applicable, here. Copyright, patents, and trademark exist for a reason.
Abuse of these structures, is the real issue.
Like people that argue for unfettered capitalism, or total legalization of all vice, we need to think about basic human nature, when discussing these things. That doesn’t happen, usually. It’s either all or nothing. We don’t consider that moderation, and benevolent structure, are possible (which they might not always be, considering human nature).
The hard part is imposing just enough structure to ensure that we get maximum effect.
About a month ago, there was a post about the “Pareto Front,” that point at which maximum desired effect is achieved, with optimal resource usage, and side effects. The zenith.
That can also apply to social infrastructure, but it’s really, really difficult, and lawyers and social scientists don’t think that way.
I honestly feel as if very few people take basic human nature into account, when designing pretty much anything.
I seem to remember a guy living in a cabin, writing manifestos, and mailing bombs to tech people and academics.
If that's true then that value system is entirely messed up and needs to be burned to the ground and rebuilt.
It’s so rare for any work to still be making money that long that it would hardly change the calculation.
I think most people are in support of some financial incentives via protection, but 70 years is just insane.